Fagron
Fagron, a leading global player in the pharmaceutical industry, is headquartered in the Netherlands (NL) and operates extensively across Europe, North America, and Latin America. Founded in 1990, the company has established itself as a pioneer in customised medicines, focusing on compounding and innovative pharmaceutical solutions tailored to individual patient needs. Fagron's core offerings include a diverse range of pharmaceutical products and services, such as sterile and non-sterile compounding, as well as advanced drug delivery systems. What sets Fagron apart is its commitment to quality and innovation, ensuring that healthcare professionals have access to tailored therapies that enhance patient outcomes. With a strong market position and a reputation for excellence, Fagron continues to achieve significant milestones in the pharmaceutical sector, reinforcing its status as a trusted partner in personalised medicine.
DitchCarbon Score
How does Fagron's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Health Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Fagron's score of 59 is higher than 99% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Fagron's reported carbon emissions
In 2023, Fagron reported total carbon emissions of approximately 273,399,000 kg CO2e. This figure includes 4,274,000 kg CO2e from Scope 1 emissions, 8,639,000 kg CO2e from Scope 2 emissions (market-based), and a significant 260,486,000 kg CO2e from Scope 3 emissions. The company has set ambitious targets to reduce its greenhouse gas emissions, aiming for a 42% reduction in absolute Scope 1 and 2 emissions by 2030, based on a 2021 baseline. Additionally, Fagron is committed to reducing Scope 3 emissions by 25% for selected categories within the same timeframe. Furthermore, by 2027, the company aims for 60% of its suppliers, based on emissions from purchased goods and services, to have science-based targets. These commitments align with industry standards and reflect Fagron's dedication to addressing climate change and reducing its environmental impact.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|
| Scope 1 | 2,818,000 | 0,000,000 | 0,000,000 | 0,000,000 | 0,000,000 | 0,000,000 |
| Scope 2 | 8,200,000 | 0,000,000 | 0,000,000 | 0,000,000 | 0,000,000 | 0,000,000 |
| Scope 3 | 2,477,000 | 000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Fagron is participating in some of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
